Bullish
$AMRN All IMO. The MRC Citizens Petition denial got my whole attention today. A CP contains challenges so that FDA discovery during label negotiations might create merit for the CP, thus a new label decision would normally be arrived at prior to the denial. All citizens petitions submitted prior to a cutoff around label negotiatiins would then be reviewed and dispensed prior to public announcement of the sNDA. So I think Vascepa has a new label already pending some quick FDA house cleaning issues.
  • 10
  • 4